-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nizubaglustat in Niemann-Pick Disease Type C
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nizubaglustat in Niemann-Pick Disease Type C report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nizubaglustat in Niemann-Pick Disease Type C Drug Details: AZ-3102...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AZ-3102 in Tay-Sachs Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AZ-3102 in Tay-Sachs Disease Drug Details: AZ-3102 is under development for the treatment of GM1...
-
Company Insights
Innovation and Patenting activity of Nam Tai Property Inc. Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Nam Tai Property Inc. Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Company Insights
Innovation and Patenting activity of Feng Tay Enterprises Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Feng Tay Enterprises Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TQB-3454 in Astrocytoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TQB-3454 in Astrocytoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TQB-3454 in Astrocytoma Drug Details: TQB-3454 is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TQB-2858 in Nasopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TQB-2858 in Nasopharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TQB-2858 in Nasopharyngeal Cancer Drug Details: TQB-2858 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HT-6184 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HT-6184 in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HT-6184 in Alzheimer's Disease Drug Details: The drug candidate is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TQB-2858 in Malignant Neoplasms
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TQB-2858 in Malignant Neoplasms report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TQB-2858 in Malignant Neoplasms Drug Details: TQB-2858 is under development for the...
-
Thematic Analysis
Construction M&A Deals 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Construction Sector